Eloxx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,356 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 776-800 of 923 matching filings.

Per page
25
Current page
32
DEF 14A File 001-31326

FORM DEF 14A

Filing date
01 Nov 2011
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-177586

REGISTRATION STATEMENT

Filing date
28 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K CURRENT REPORT

Filing date
26 Oct 2011
Reporting date
26 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
26 Oct 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-31326

FORM 10-K/A

Filing date
24 Oct 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-31326

PRE 14A filing

Filing date
18 Oct 2011
Reporting date
18 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A -

Filing date
17 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
29 Sep 2011
Reporting date
29 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-31326

FORM 10-K

Filing date
28 Sep 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
24 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
08 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
20 Jun 2011
Reporting date
20 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
14 Jun 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .